Evidence map›Paper›PMID 39802823›Full record

ArticleVirus evolution2025

Comprehensive molecular epidemiology of influenza viruses in Brazil: insights from a nationwide analysis.

Isabela Carvalho Brcko, Vinicius Carius de Souza, Gabriela Ribeiro, Alex Ranieri Jeronimo Lima, Antonio Jorge Martins, Claudia Renata Dos Santos Barros, Eneas de Carvalho, James Siqueira Pereira, Loyze Paola Oliveira de Lima, Vincent Louis Viala and 36 more

Abstract read
In one paragraph

Article in Virus evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Isabela Carvalho BrckoCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.ORCID https://orcid.org/0000-0002-6036-520X
Vinicius Carius de SouzaCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Gabriela RibeiroCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Alex Ranieri Jeronimo LimaCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Antonio Jorge MartinsCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Claudia Renata Dos Santos BarrosCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Eneas de CarvalhoInstituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
James Siqueira PereiraCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Loyze Paola Oliveira de LimaCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Vincent Louis VialaCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Simone KashimaCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Debora Glenda Lima de La RoqueHemocentro Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, São Paulo 14051-140, Brazil.
Elaine Vieira SantosHemocentro Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, São Paulo 14051-140, Brazil.
Evandra Strazza RodriguesHemocentro Ribeirão Preto, Rua Tenente Catão Roxo, 2501, Ribeirão Preto, São Paulo 14051-140, Brazil.
Juliana Almeida NunesCoordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de Saúde (SMS/SP), Prefeitura São Paulo, Rua Siqueira Campos, 176, São Paulo, São Paulo 01509-020, Brazil.
Leandro Spalato TorresCoordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de Saúde (SMS/SP), Prefeitura São Paulo, Rua Siqueira Campos, 176, São Paulo, São Paulo 01509-020, Brazil.
Luiz Artur Vieira CaldeiraCoordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de Saúde (SMS/SP), Prefeitura São Paulo, Rua Siqueira Campos, 176, São Paulo, São Paulo 01509-020, Brazil.
Melissa PalmieriCoordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de Saúde (SMS/SP), Prefeitura São Paulo, Rua Siqueira Campos, 176, São Paulo, São Paulo 01509-020, Brazil.
Caio Genovez MedinaDepartamento de Atenção Hospitalar de São Bernardo do Campo, Prefeitura São Bernardo do Campo, Rua João Pessoa, 59, São Bernardo do Campo, São Paulo 09715-000, Brazil.
Raphael Augusto de ArrudaDepartamento de Atenção Hospitalar de São Bernardo do Campo, Prefeitura São Bernardo do Campo, Rua João Pessoa, 59, São Bernardo do Campo, São Paulo 09715-000, Brazil.
Renata Beividas LopesDepartamento de Atenção Hospitalar de São Bernardo do Campo, Prefeitura São Bernardo do Campo, Rua João Pessoa, 59, São Bernardo do Campo, São Paulo 09715-000, Brazil.
Geraldo Reple SobrinhoSecretaria de Saúde de São Bernardo do Campo, Prefeitura São Bernardo do Campo, Rua João Pessoa, 59, São Bernardo do Campo, São Paulo 09715-000, Brazil.
Daniel Macedo de Melo JorgeFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Avenida dos Bandeirantes, 3900, Ribeirão Preto, São Paulo 14048-900, Brazil.
Eurico ArrudaFaculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Avenida dos Bandeirantes, 3900, Ribeirão Preto, São Paulo 14048-900, Brazil.
Eladja Christina Bezerra da Silva MendesLaboratório Central de Saúde Pública do Estado de Alagoas (LACEN-AL), Rua Doutor Ernesto Gomes Maranhão, 1773, Maceió, Alagoas 57036-860, Brazil.
Hazerral de Oliveira SantosLaboratório Central de Saúde Pública do Estado de Alagoas (LACEN-AL), Rua Doutor Ernesto Gomes Maranhão, 1773, Maceió, Alagoas 57036-860, Brazil.
Arabela Leal E Silva de MelloLaboratório Central de Saúde Pública do Estado da Bahia (LACEN-BA), 4ª Avenida, 400, Salvador, Bahia 41745-900, Brazil.
Felicidade Mota PereiraLaboratório Central de Saúde Pública do Estado da Bahia (LACEN-BA), 4ª Avenida, 400, Salvador, Bahia 41745-900, Brazil.
Marcela Kelly Astete GómezLaboratório Central de Saúde Pública do Estado da Bahia (LACEN-BA), 4ª Avenida, 400, Salvador, Bahia 41745-900, Brazil.
Vanessa Brandão NardyLaboratório Central de Saúde Pública do Estado da Bahia (LACEN-BA), 4ª Avenida, 400, Salvador, Bahia 41745-900, Brazil.
Brenno HenriqueLaboratório Central de Saúde Pública do Distrito Federal (LACEN-DF), Lotes O e P, Sgan 601, Brasília, Distrito Federal 70.830-010, Brazil.
Lucas Luiz VieiraLaboratório Central de Saúde Pública do Distrito Federal (LACEN-DF), Lotes O e P, Sgan 601, Brasília, Distrito Federal 70.830-010, Brazil.ORCID https://orcid.org/0000-0002-4810-1236
Mariana Matos RollLaboratório Central de Saúde Pública do Distrito Federal (LACEN-DF), Lotes O e P, Sgan 601, Brasília, Distrito Federal 70.830-010, Brazil.
Elaine Cristina de OliveiraLaboratório Central de Saúde Pública do Estado de Mato Grosso (LACEN-MT), Rua Santiago, 70, Cuiabá, Mato Grosso 78.060-628, Brazil.
Júlia Deffune Profeta Cidin AlmeidaLaboratório Central de Saúde Pública do Estado de Mato Grosso (LACEN-MT), Rua Santiago, 70, Cuiabá, Mato Grosso 78.060-628, Brazil.
Stephanni Figueiredo da SilvaLaboratório Central de Saúde Pública do Estado de Mato Grosso (LACEN-MT), Rua Santiago, 70, Cuiabá, Mato Grosso 78.060-628, Brazil.
Gleissy Adriane Lima BorgesLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, Pará 66823-010, Brazil.
Katia Cristina de Lima FurtadoLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, Pará 66823-010, Brazil.
Patricia Miriam Sayuri Sato Barros da CostaLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, Pará 66823-010, Brazil.
Shirley Moreira da Silva ChagasLaboratório Central de Saúde Pública do Estado do Pará (LACEN-PA), Rodovia Augusto Montenegro, 524, Belém, Pará 66823-010, Brazil.
Esper G KallásInstituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Daniel LarhInstituto de Biociências, Universidade de São Paulo, Rua do Matão, 321, São Paulo, São Paulo 05508-090, Brazil.
Marta GiovanettiDepartment of Science and Technology for Humans and the Environment, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, Rome 00128 Rome, Italy.ORCID https://orcid.org/0000-0002-5849-7326
Svetoslav Nanev SlavovCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Sandra Coccuzzo SampaioCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.
Maria Carolina EliasCenter for Viral Surveillance and Serological Assessment (CeVIVAS), Instituto Butantan, Avenida Vital Brasil, 1500, Butantã, São Paulo, São Paulo 05503-900, Brazil.ORCID https://orcid.org/0000-0002-0501-8280

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A and B viruses represent significant global health threats, contributing substantially to morbidity and mortality rates. However, a comprehensive understanding of the molecular epidemiology of these viruses in Brazil, a continental-size country and a crucial hub for the entry, circulation, and dissemination of influenza viruses within South America, still needs to be improved. This study addresses this gap by consolidating data and samples across all Brazilian macroregions, as part of the Center for Viral Surveillance and Serological Assessment project, together with an extensive number of other Brazilian sequences provided by a public database during the epidemic seasons spanning 2021-23. Phylogenetic analysis of the hemagglutinin segment of influenza A/H1N1pdm09, A/H3N2, and influenza B/Victoria-lineage viruses revealed that in 2021 and in the first semester of 2022, the A/H3N2 2a.3 strain was the predominant circulating strain. Subsequently, the A/H3N2 2b became the prevalent strain until October, when it was substituted by A/H1N1pdm09 5a.2a and 5a.2a.1 lineages. This scenario was maintained during the year of 2023. B/Victoria emerged and circulated at low levels between December 2021 and September 2022 and then became coprevalent with A/H1N1pdm09 5a.2a and 5a.2a.1 lineages. The comparison between the vaccine strain A/Darwin/9/2021 and circulating viruses revealed shared mutations to aspartic acid at residues 186 and 225 across all A/H3N2 lineages from 2021 to 2023, altering the charge in the receptor-binding domain. For A/H1N1pdm09, the 2022 consensus of 5a.2a.1 and the vaccine strain A/Victoria/2570/2019 showed 14 amino acid substitutions. Key residues H180, D187, K219, R223, E224, and T133 are involved in hydrogen interactions with sialic acids, while N130, K142, and D222 may contribute to distance interactions based on docking analyses. Importantly, distinct influenza A lineage frequency patterns were observed across Brazil's macroregions, underscoring the regional variations in virus circulation. This study characterizes influenza A and B viruses circulating in Brazil, providing insights into their circulation patterns and dynamics across Brazilian macroregions. These findings hold significant implications for public health interventions, informing strategies to mitigate transmission risks, optimize vaccination efforts, and enhance outbreak control measures.

Indexed as

genomic surveillanceinfluenza Ainfluenza Bmolecular dockingphylogenyprotein structure predictionvaccine strains

Identifiers

PMID39802823
PMCPMC11711486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.